DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Modi S, Park H, Murthy RK. et al.
Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib Study.
J Clin Oncol 2020;
DOI: 10.1200/JCO.19.02318.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.